Walgreens Magnesium Citrate Laxative Recalled for Microbial Contamination
Walgreens Dye-Free Magnesium Citrate Saline Laxative is recalled nationwide due to microbial contamination affecting certain lots. Consumers should stop using the product immediately.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This recall is classified by the FDA as Class I, which requires a minimum severity score of 4. Microbial contamination of a non-sterile pharmaceutical product poses a serious health risk, though no illnesses or injuries have been reported.
Plain-English summary
Walgreens Dye-Free Magnesium Citrate Saline Laxative, 10 FL OZ bottles in Grape Flavor, is being recalled nationwide due to microbial contamination. The product was distributed in the United States, Canada, and Panama.
Lot #0506255 with expiration date 10/24/2022 is affected, with approximately 29,388 bottles involved in the recall.
Consumers should stop using this product immediately. Anyone who has consumed the product and experiences adverse health effects should contact their healthcare provider.
The recalled product
- Product
- Walgreens, Dye-Free, Magnesium Citrate, SALINE LAXATIVE, Oral Solution, (1.745 g/fl oz), Grape Flavor, 10 FL OZ (296 mL), Distributed By: Walgreen Co., 200 Wilmot RD., Deerfield, IL 60015; NDC 0363-7162-38 UPC 3 11917 20159 7 (purple label).
- Manufacturer
- Vi-Jon, LLC
- Category
- Drug — Oral Laxative
- Hazard
- microbial-contamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # 0506255
- EXP 10/24/2022
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27